Global Proton Therapy Market Report: Insights, Trends & Forecast (2019-2023)
The global market for proton therapy is dominated by North American region.
By: Koncept Analytics
The growth in the proton therapy market is mainly driven by factors such as increasing cancer prevalence, higher ageing population, rising healthcare expenditures and advantageous properties of proton therapy over photon therapy.
Some factors that hinder the growth of market are stringent regulations, barriers to implementation and high installation cost of the therapy. To overcome the challenges, there exist few trends and developments in the market. The following are the trends- reducing per room cost of proton therapy, technological up gradations, rising public awareness and introduction of LIGHT.
The global market for proton therapy is dominated by North American region. The proton therapy market in North America is growing due to the rising ageing population and increasing number of cancer patients. As the awareness and adoption of proton therapy increases, the market also expands. To support this, the facilities and availability of centers for treatment has also increased.
Scope of the report:
• The report provides a comprehensive analysis of the global proton therapy market.
• The major regional markets (North America, Europe and Asia Pacific) have been analyzed, along with country coverage of US.
• The market dynamics such as growth drivers, market trends and challenges are analyzed in-depth.
• The competitive landscape of the market, along with the company profiles of leading players (IBA, Varian Medical Systems, Hitachi, Ltd., Sumitomo Corporation, Accuray Incorporated and Elekta) are also presented in detail.
For more Information:
(Business Development Manager)
FFCS-36, Ansal Plaza
U.P - 201010
Mail ID – email@example.com